QLY Biotech Group (QLY Biotech Group) EBIT per Share : $-0.01 (TTM As of Feb. 2023)

View and export this data going back to 2021. Start your Free Trial

What is QLY Biotech Group EBIT per Share?

QLY Biotech Group's EBIT per Share for the three months ended in Feb. 2023 was $-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2023 was $-0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for QLY Biotech Group's EBIT per Share or its related term are showing as below:

LQLY's 3-Year EBIT Growth Rate is not ranked ^*
in the Travel & Leisure industry.
Industry Median: 14.75
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

QLY Biotech Group's EBIT for the three months ended in Feb. 2023 was $-0.01 Mil.

QLY Biotech Group EBIT per Share Historical Data

The historical data trend for QLY Biotech Group's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QLY Biotech Group EBIT per Share Chart

QLY Biotech Group Annual Data

Trend

Aug19

Aug20

Aug21

Aug22

EBIT per Share

-0.01

QLY Biotech Group Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23
EBIT per Share	Get a 7-Day Free Trial												-	-	-	-	-

QLY Biotech Group EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

QLY Biotech Group's EBIT per Share for the fiscal year that ended in Aug. 2022 is calculated as

	EBIT per Share		(A: Aug. 2022 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.014	/	3.895
=	-0.00

QLY Biotech Group's EBIT per Share for the quarter that ended in Feb. 2023 is calculated as

	EBIT per Share		(Q: Feb. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.012	/	3.895
=	-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Feb. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

QLY Biotech Group (OTCPK:LQLY) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

QLY Biotech Group EBIT per Share Related Terms

Thank you for viewing the detailed overview of QLY Biotech Group's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

QLY Biotech Group (QLY Biotech Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » QLY Biotech Group Corp (OTCPK:LQLY) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

5348 Vegas Drive, Las Vegas, NV, USA, 89108

Website

QLY Biotech Group Corp is a United States based company engaged in the tourism business.

QLY Biotech Group (QLY Biotech Group) Headlines

No Headlines